Manuel D Diaz-Munoz

Science and other bits from the Diaz-Munoz lab

[Nicolas Fazilleau @N_Fazilleau]

@InfinityTLS @UT3PaulSabatier @CNRS @Inserm est seul laboratoire d'accueil pour un poste de maître de conférences en Virologie (section 65) qui va ouvrir au concours en 2025 à l'Université de Toulouse (@UT3PaulSabatier).

Les candidatures seront ouvertes à partir du 3 mars 2025

[Nicolas Fazilleau @N_Fazilleau]

@InfinityTLS @UT3PaulSabatier @CNRS @Inserm est laboratoire d'accueil, avec @IpbsToulouse et @CbiToulouse , pour un poste de maître de conférences en Biochimie (section 64) qui va ouvrir au concours en 2025 @UT3PaulSabatier
Les candidatures seront ouvertes le 3 mars 2025.

[Manuel D Diaz-Munoz @DiazMunoz_Lab]

New research assistant position in the lab. If you enjoy Immunology 👩🏽‍🔬👨🏽‍🔬 and RNA biology 🧬, and love to play with cutting-edge technologies, please check this out.

[Manuel D Diaz-Munoz @DiazMunoz_Lab]

Joyful to share another piece showing how post-transcriptional regulation controls immune cell homeostasis. This time, "the holding many secrets" innate B-1 cells and the protein HuR. A magnificent work led by Dunja and my wonderful team 👩🏽‍🔬👩‍🔬🧑🏽‍🔬👨‍🔬

https://t.co/G3D14vIqC3

[Manuel D Diaz-Munoz @DiazMunoz_Lab]

Happy to share our new piece of work!
Here we show how post-transcriptional regulation controls quiescence to keep naive T cells in good shape.
Big collaborative effort from a wonderful lovely team 👩‍🔬👩🏾‍🔬👩🏽‍🔬🧑🏽‍🔬!!!! https://t.co/m6WLxJ7Doq

[Manuel D Diaz-Munoz @DiazMunoz_Lab]

There is still time to join us @InfinityTLS @Inserm in an exciting programme combining cancer immunology, signalling and post-transcriptional regulation. Just contact us to know more.

[Zhoujie Ding @ZhoujieDing]

Have you ever wondered what Ki67 does beyond a proliferation marker? Checkout our paper in JExpMed looking at the role of Ki67 in lymphocyte development for the first time! @MonashSTM

[Vera Pancaldi verapancaldi.bsky.social @VeraPancaldi]

Remember to get in touch soon if interested (by the end of next week at the latest!) Excellent PhD opportunity for deep learning project in bioinformatics and oncology. @BSC_CNS @BU_CNIO @SysBioCurie @LauCan88 @CareGraduate @InfinityTLS @RestoreInstitut

[LifeScienceAlliance @LSAjournal]

In LSA's Immunology Collection: RNA helicase EIF4A1-mediated translation is essential for the GC response @BabrahamInst @MartT_babraham
https://t.co/zm4qw50NrE

[Manuel D Diaz-Munoz @DiazMunoz_Lab]

It's that time of the year in which we recruit the next generation of scientists for their training... No matter the background as far you love immunology and the 🇫🇷 culture, we have two offers to fill in... Check at https://t.co/8GL5VtLJlq and https://t.co/L7bxDbvscQ

[Julio Saez-Rodriguez @JulioSaezRod]

Do you want to pursue your ideas in computational biology independently, running your group in @embl ‘s uniquely collaborative environment, next to world’s most comprehensive molecular data resources + with top-notch infrastructure @emblebi? Apply to join us & pls RT

[Infinity Toulouse @InfinityTLS]

You still have time to apply!
The deadline has been extended until May 15th

@InfinityTLS @Inserm @CNRS @UT3PaulSabatier

[Infinity Toulouse @InfinityTLS]

Many open positions right now @InfinityTLS @CNRS @Inserm @UT3PaulSabatier
- 2 Assistant professor positions (Immunology/ Biochemistry-Metabolism) with @UT3PaulSabatier
- 1 Chair in Biotherapy with @Inserm

And still a call for Group leaders

more information on previous posts!

[Infinity Toulouse @InfinityTLS]

Another open postion at @InfinityTLS : @Inserm Chair in Biotherapy

The position is offered on a fixed-term contract (5 years) with a view to tenure as @Inserm Research Director at the end of the contract

More information here: https://t.co/K919t7lMsj

[Infinity Toulouse @InfinityTLS]

Join Us !

[Nature Methods @naturemethods]

ARTR-seq uses antibody-guided in situ reverse transcription to efficiently, accurately identify RNA-binding protein target sites. @UChicago
https://t.co/0juUNqryXC

[Journal of Experimental Medicine @JExpMed]

.@EmelineJ66, @asdejean et al. @InfinityTLS reveal a new mechanism whereby the transcription factor Eomes promotes CD4+ T cell accumulation in inflamed tissue thru. increased mitochondrial functions & resistance to cell death https://t.co/NPcYxtCbQu
@MFMich1 @jeansarry @lyacts

[IdoAmitLab @IdoAmitLab]

We are very excited to present the development of Zman-seq (“Zman”, Hebrew for “time”), the 1st technology that measures single-cell transcriptomes and physical time in vivo, led by @D_Birschenkaum, @CuriousKX, @FlorianIngelfi1, @AssafWeiner
https://t.co/pDk6ackAtV. (1/19)

[Roychoudhuri Lab @RoychoudhuriLab]

Fantastic to share new work led by @SarahKWhiteside published today in @SciImmunology. We find that CD4+ conventional T cells acquire suppressive functions upon Treg depletion limiting efficacy of Treg-targeted therapies. Collaboration with @luglilab🧵👇
https://t.co/5TPfwxf2jq

[Uttiya Basu @basulabcolumbia]

Our study on somatic hypermutation induced lymphoma progression #enhancers #promoters #lymphoma #SHM #rRNA #AID
https://t.co/ledRTTyl4a

Thank you Columbia & VP&S for a nice coverage. @ColumbiaPS @columbiacancer
-----

What Makes Lymphoma Turn Lethal? https://t.co/H9mKaB3z4a